# Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)

> **NCT06712420** · PHASE3 · RECRUITING · sponsor: **Rajiv Gandhi Cancer Institute & Research Center, India** · enrollment: 114 (estimated)

## Conditions studied

- Gall Bladder Carcinoma

## Interventions

- **DRUG:** neoadjuvant chemotherapy
- **PROCEDURE:** curative surgery

## Key facts

- **NCT ID:** NCT06712420
- **Lead sponsor:** Rajiv Gandhi Cancer Institute & Research Center, India
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2028-04
- **Final completion:** 2028-12
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2025-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06712420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06712420, "Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06712420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*